German Remedies Pharmaceuticals Private Limited is an unlisted private company incorporated on 29 December, 2010. It is classified as a private limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 70.00 cr and the total paid-up capital is INR 66.83 cr.

UMEDICA is a manufacturer and exporter of Pharmaceutical Formulations viz; Injectable, Tablets, Capsules, Suspensions, Dry Syrups, etc. Since our inception in 1982, we have established ourselves as a company delivering products meeting international quality standards.

UMEDICA LABORATORIES invites dedicated, passionate & competent young professionals to be part of our USFDA, EU GMP and TGA Australia approved formulations manufacturing plant UMEDICA LABORATORIES at VAPI, GUJARAT for following requirement.

Glenmark Pharmaceuticals Limited a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp. today announced launch of its Nitric Oxide Nasal Spray under the brand name FabiSpray in India; for the treatment of adult patients with COVID-19 who have high risk of progression of the disease. Glenmark earlier received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) for NONS as part of the accelerated approval process.

A team of scientists has developed a new technology, platform for fluorometric detection of pathogens such as viruses by measurement of fluorescent light emitted. The potential of the new technology has been demonstrated for the detection of SARS-CoV-2. This technology platform can also be used to detect other DNA/RNA pathogens such as HIV, influenza, HCV, Zika, Ebola, bacteria, and other mutating/evolving pathogens.

The National Health Authority (NHA) under its flagship scheme of Ayushman Bharat Digital Mission (ABDM) announced completion of 27 major integrations across Government and private sector. These integrations with organizations offering Health Management Information Systems (HMIS), Laboratory Management Information Systems (LMIS), health locker services, health tech services and other digital services are a step towards developing a user-inclusive, integrated and interoperable digital healthcare eco-system for the country.

Wockhardt Limited has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.

Wockhardts Bulk vaccine and Fill-Finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly inspected and approved by Drug inspectors from CDSCO (West zone) & Aurangabad State FDA and Expert from CDL Kasauli to receive export NOC.

Health and Family Welfare Department has created wide network of health and medical care facilities in the state to provide primary, secondary and tertiary health care at the door step of every citizen of Gujarat with prime focus on BPL families and weaker sections in rural/urban slum areas. Department also takes appropriate actions to create adequate educational facilities for medical and paramedical manpower in the state of Gujarat.

Post : Junior Pharmacist

Tamil Nadu Industrial Development Corporation Limited is the industrial development agency of the Government of Tamil Nadu, established in 1965. TIDCO endeavours to achieve a balanced and continual industrial growth by promoting medium and large industries in the state through Joint Ventures.

Applications are invited for the following Posts on Contract / Out Sourcing Basis under the control of DCHS, Vizianagaram. Applications shall submit to the DCHS Office, District Hospital Campus, Vizianagaram in the prescribed format.

Post : Pharmacists Grade - II

The School of Pharmacy came into existence in the year 2015, with academic programs D. Pharm., B. Pharm. and Ph.D. From the academic session 2019-20, the Pharmacy Council of India (PCI) has approved the increase in the intake of B. Pharm to 100 seats. Both D. Pharm and B. Pharm programs are duly approved by the PCI under section 12 of Pharmacy Act 1948. All the courses are approved by HPPERC and Government of Himachal. Every year, the faculties are participating in FDPs, Conferences, Workshops.

Applications are invited from qualified and eligible candidates for filling up of the posts of Paramedical and others on Contract/Out Sourcing basis in APVVP Hospitals in Srikakulam District institutions in Commissioner, A.P. Vaidya Vidhana Parishad, Vijayawada.

Post : Pharmacist

Application are Invited ON 2nd CALL by Issuing Re -Notification for the Un Filling of Certain Posts i.e 01 Posts of Pharmacist Grade II on Contract Basis under the Administrative Control of District Medical & Health Officer, Vizianagaram.

Post : Pharmacists Grade -II

Applications are invited from eligible candidates for recruitment of the following posts to work at A.P.Vaidya Vidhana Parishad Hospitals in E.G.District on contract basis/outsourcing basis.

Post : Pharmacist Gr.II

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients in the world.

Abryl Laboratories was incorporated in 2016 with a single mission to provide the global market with high quality sterile liquid and lyophilised products. Over the course of time, Abryl has expanded its operations to pre-filled syringes as well.

Post : AM/Sr. Executive, Executive/Operator

Microbiology
Quality Control
ARD & FRD
Production & Packing

Critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib. Doctors call this drug bari, and receiving the pill once a day for up to 14 days yielded one of the largest a survival advantages seen yet in the COVID pandemic, according to a study published.

A revolutionary pacemaker that re-establishes the hearts naturally irregular beat is set to be trialled in New Zealand heart patients this year, following successful animal trials. Currently, all pacemakers pace the heart metronomically, which means a very steady, even pace. But when you record heart rate in a healthy individual, you see it is constantly on the move, says Professor Julian Paton, a lead researcher and director of Manaaki Manawa, the Centre for Heart Research at the University of Auckland.

IIHMR University is a specialized research University in management research, postgraduate education and training in the health sector. The University aims to generate new knowledge and technologies to provide evidence and inputs for developing effective policies and health interventions and strategies.

Two years into the pandemic, health systems are still facing significant challenges in providing essential health services. Ongoing disruptions have been reported in over 90 percent of countries surveyed in the third round of WHOs Global pulse survey on continuity of essential health services during the COVID-19 pandemic.